GlassScriptPhysician profile
Steven Cohn
NPI 1649290453
$9,509.23
in general payments reported to CMS, 2019-2025
38 companies · $718 in 2025
The $718 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,880 · 2020: $1,199 · 2021: $1,819 · 2022: $1,171 · 2023: $810 · 2024: $1,911 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,439.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,242.47 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,090.48 | 2019-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $967.31 | 2021-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $910.71 | 2019-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Perclose Prostyle |
| Pfizer INC. | $888.41 | 2019-2025 | |
| Amarin Pharma, INC. | $593.88 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $471.59 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $451.20 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $407.88 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $302.49 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $270.88 | 2021-2025 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $263.91 | 2019-2024 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $260.74 | 2019-2025 | Lifevest |
| Cvrx, INC. | $203.81 | 2023-2024 | Barostim Neo System |
| Boston Scientific Corporation | $155.91 | 2019-2025 | Watchman Flx |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.